Search

Two intraperitoneal chemotherapy approaches are being compared for effectiveness and toxicity in Memorial Sloan Kettering Cancer Center’s phase II clinical trial, which continues to enroll cytoreductive cancer surgery patients with isolated peritoneal metastasis.

… Thursday, May 19, 2016 After surgical cytoreduction Figure 1. After surgical cytoreduction, percutaneous inflow and outflow catheters and IP temperature probes are placed in the peritoneal cavity. The catheters are connected to the perfusion system, and normal saline is heated to 41-43°C and circulated

Paige Arnold, who will graduate from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) next spring, has been awarded the 2022 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Emeritus Louis V. Gerstner, Jr., for whom the school is named.

… Friday, September 9, 2022 Paige Arnold , who will graduate from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) next spring, has been awarded the 2022 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Emeritus

A new drug delivery method could improve treatment of a lethal pediatric brain tumor called diffuse intrinsic pontine glioma.

… Friday, March 14, 2025 Brain tumors are one of the most difficult cancers to treat because of the blood-brain barrier, which protects the brain against toxins. That barrier also means treatments such as chemotherapy  can’t be delivered to tumors in high enough concentrations to be effective. As a result

The final survival analysis of an international study of a new drug for prostate cancer has found an even greater median survival benefit than previously reported, and has established a new class of treatment for men with metastatic prostate cancer. In addition, researchers are exploring a potential biomarker of response to treatment in general.

… Saturday, June 4, 2011 The final survival analysis of an international study of a new drug for prostate cancer has found an even greater median survival benefit than previously reported, and has established a new class of treatment for men with metastatic prostate cancer. In addition, researchers are

Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA (mRNA) can inactivate the functions of tumor suppressor genes and thereby promote cancer. The findings pinpoint previously unknown drivers of the disease, indicating that cancer diagnostics need to go beyond the analysis of DNA mutations.

… Monday, August 27, 2018 Bottom Line: Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA (mRNA) can inactivate the functions of tumor suppressor genes and thereby promote cancer. The findings pinpoint previously unknown drivers

Receiving five or more cycles of neoadjuvant chemotherapy was associated with worse progression-free survival (PFS) and overall survival (OS) compared to receiving three or four cycles — despite maximal surgical cytoreduction.

… Friday, November 13, 2020 Receiving five or more cycles of neoadjuvant chemotherapy was associated with worse progression-free survival (PFS) and overall survival (OS) compared to receiving three or four cycles — despite maximal cytoreduction — according to a retrospective analysis of patients with newly-diagnosed

On June 7 when Memorial Sloan Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital.

… Thursday, July 1, 2010 Summary On June 7 when Memorial Sloan Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital. A vision of creating a state-of-the-art treatment center in which multiple

By assuming primitive regenerative identities, cancer cells gain the adaptability they need to establish tumors in new parts of the body.

… Monday, February 10, 2020 Summary Scientists have discovered that cancer cells rely on the biology of regeneration, wound healing, and embryonic development to spread to other organs and escape detection by the immune system. Just as people tend to become stuck in their ways as they grow older so too

Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib.

… Wednesday, November 23, 2011 Research led by investigators at Memorial Sloan Kettering Cancer Center has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib, an oral targeted therapy used to treat advanced melanoma whose tumors contain a mutation in

Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer.

… Monday, January 6, 2014 Summary Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer. Memorial Sloan Kettering is one of six elite academic institutions to share an unprecedented total of $540 million